C - Chemistry – Metallurgy – 07 – H
Patent
C - Chemistry, Metallurgy
07
H
C07H 21/00 (2006.01) A61K 31/70 (2006.01) C12N 15/11 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2191191
Disclosed are synthetic oligonucleotides 15 to 50 nucleotides in length which are specifically hybridizable with at least a portion of RNA or DNA derived from the UL36, UL84, UL101x-102, or UL112-113 genes of a cytomegalovirus. Also disclosed are pharmaceutical compositions including an oligonucleotide of the invention and methods of inhibiting cytomegalovirus infection using such oligonucleotides.
La présente invention a pour objet des oligonucléotides, de 15 à 50 nucléotides de long, qui peuvent être hybridés de manière spécifique avec au moins une partie d'ARN ou d'ADN dérivée des gènes UL36, UL84, UL101x-102, ou UL112-113 d'un cytomégalovirus. L'invention traite également de compositions pharmaceutiques comprenant un oligonucléotide selon la présente invention et des procédés pour inhiber l'infection par le cytomégalovirus à l'aide de ces oligonucléotides.
Hybridon Inc.
Mbm & Co.
LandOfFree
Oligonucleotides with anti-cytomegalovirus activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligonucleotides with anti-cytomegalovirus activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleotides with anti-cytomegalovirus activity will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1888420